The IBN SINA Pharmaceutical Industry PLC

DSE:IBNSINA Stock Report

Market Cap: ৳9.9b

IBN SINA Pharmaceutical Industry Balance Sheet Health

Financial Health criteria checks 5/6

IBN SINA Pharmaceutical Industry has a total shareholder equity of BDT3.4B and total debt of BDT1.5B, which brings its debt-to-equity ratio to 45.8%. Its total assets and total liabilities are BDT6.2B and BDT2.8B respectively. IBN SINA Pharmaceutical Industry's EBIT is BDT952.9M making its interest coverage ratio 20.8. It has cash and short-term investments of BDT495.9M.

Key information

45.8%

Debt to equity ratio

৳1.54b

Debt

Interest coverage ratio20.8x
Cash৳495.93m
Equity৳3.37b
Total liabilities৳2.83b
Total assets৳6.20b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: IBNSINA's short term assets (BDT2.4B) exceed its short term liabilities (BDT2.3B).

Long Term Liabilities: IBNSINA's short term assets (BDT2.4B) exceed its long term liabilities (BDT570.9M).


Debt to Equity History and Analysis

Debt Level: IBNSINA's net debt to equity ratio (31.1%) is considered satisfactory.

Reducing Debt: IBNSINA's debt to equity ratio has increased from 41.8% to 45.8% over the past 5 years.

Debt Coverage: IBNSINA's debt is well covered by operating cash flow (52.8%).

Interest Coverage: IBNSINA's interest payments on its debt are well covered by EBIT (20.8x coverage).


Balance Sheet


Discover healthy companies